GB0006716D0 - Virus or viral antigen purification method and vaccine producing method - Google Patents
Virus or viral antigen purification method and vaccine producing methodInfo
- Publication number
- GB0006716D0 GB0006716D0 GBGB0006716.5A GB0006716A GB0006716D0 GB 0006716 D0 GB0006716 D0 GB 0006716D0 GB 0006716 A GB0006716 A GB 0006716A GB 0006716 D0 GB0006716 D0 GB 0006716D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- viral antigen
- antigen purification
- vaccine producing
- purification method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11073915A JP2000262280A (en) | 1999-03-18 | 1999-03-18 | Purification of virus or viral antigen and prodution of vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0006716D0 true GB0006716D0 (en) | 2000-05-10 |
GB2348886A GB2348886A (en) | 2000-10-18 |
Family
ID=13531951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0006716A Withdrawn GB2348886A (en) | 1999-03-18 | 2000-03-20 | Virus or viral antigen purification method and vaccine producing method |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2000262280A (en) |
DE (1) | DE10013017A1 (en) |
FR (1) | FR2791698A1 (en) |
GB (1) | GB2348886A (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020064860A1 (en) | 2000-11-29 | 2002-05-30 | Schering Corporation | Method for purifying adenoviruses |
CN101329955B (en) * | 2007-06-22 | 2011-07-06 | 西门子公司 | Double operation handle apparatus |
WO2010038719A1 (en) | 2008-09-30 | 2010-04-08 | デンカ生研株式会社 | Method for producing purified influenza virus antigen |
JP2011097918A (en) | 2009-10-07 | 2011-05-19 | Hoya Corp | Purification method and method for producing vaccine |
CN103013932B (en) * | 2012-12-26 | 2014-11-05 | 宁波大学 | Quick purifying method of portunus trituberculatus reovirus |
WO2021002257A1 (en) * | 2019-07-04 | 2021-01-07 | 株式会社カネカ | Method for purifying virus or virus-like particle |
JP6898535B1 (en) * | 2020-06-16 | 2021-07-07 | HOYA Technosurgical株式会社 | Virus purification method using apatite column |
EP4206329A1 (en) * | 2020-08-28 | 2023-07-05 | Kaneka Corporation | Method for purifying useful substance |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3888079T2 (en) * | 1987-10-22 | 1994-07-14 | Asahi Optical Co Ltd | Porous ceramic material. |
JPH01230413A (en) * | 1988-03-11 | 1989-09-13 | Kanto Chem Co Inc | Production of spherical hydroxyapatite sintered form and chromatographic filler consisting thereof |
SI1105466T1 (en) * | 1998-08-14 | 2006-08-31 | Merck & Co Inc | Process for purifying human papillomavirus virus-like particles |
-
1999
- 1999-03-18 JP JP11073915A patent/JP2000262280A/en active Pending
-
2000
- 2000-03-17 DE DE10013017A patent/DE10013017A1/en not_active Withdrawn
- 2000-03-20 FR FR0003558A patent/FR2791698A1/en active Pending
- 2000-03-20 GB GB0006716A patent/GB2348886A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE10013017A1 (en) | 2000-09-21 |
GB2348886A (en) | 2000-10-18 |
FR2791698A1 (en) | 2000-10-06 |
JP2000262280A (en) | 2000-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2337755B (en) | Virus vaccine | |
HK1077601A1 (en) | Genetic vaccine against human immunodeficiency virus | |
PL321966A1 (en) | Vaccine against viral hepatitis of b type | |
HK1046243A1 (en) | Aids virus vaccines using sendai virus vector | |
HK1048436A1 (en) | Vaccine against hbv and hpv | |
IL150961A0 (en) | Human immunodeficiency virus vaccine | |
AU8207301A (en) | Purification of hbv antigens for use in vaccines | |
IL162236A0 (en) | Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use | |
IL157251A0 (en) | Hepatitis b virus treatment | |
GB0006716D0 (en) | Virus or viral antigen purification method and vaccine producing method | |
IL131212A0 (en) | Recombinant virus and live-virus vaccines | |
AU2292600A (en) | Varicella-zoster virus vaccines | |
IS5777A (en) | Vaccine hepatitis B virus variants and its use | |
AU4529401A (en) | Aids ancestral viruses and vaccines | |
HUP0202770A3 (en) | Human papilloma virus vaccine | |
AU2002212073A1 (en) | A classical swine fever virus epitope vaccine and its producing method | |
IL139269A0 (en) | Hepatitis vaccine | |
EP1210364A4 (en) | Vaccine antigens of moraxella | |
AU6964001A (en) | Vaccine against the influenza virus and method for producing said virus vaccine | |
AU4957800A (en) | Vaccine against isa virus | |
AU4606000A (en) | Vaccine for newcastle disease virus | |
AU2001269640A1 (en) | Vaccine against the influenza virus and method for producing said virus vaccine | |
GB9917981D0 (en) | Viral vaccine | |
SI1436397T1 (en) | Hepatitis c virus vaccine | |
HU0400424D0 (en) | Hepatitis virus vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |